NCT02619617View on ClinicalTrials.gov

Safety and Efficacy Study of SOM230 s.c. in Cluster Headache

PHASE2TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 25, 2018

Study Completion Date

September 25, 2018

Conditions
Cluster Headache - Episodic and Chronic
Interventions
DRUG

SOM230

The study evaluated SOM230 vs Placebo

DRUG

Placebo

The study evaluated SOM230 vs Placebo

Trial Locations (4)

19107

Novartis Investigative Site, Philadelphia

61462

Novartis Investigative Site, Königstein im Taunus

90230

Novartis Investigative Site, Culver City

SE5 9RS

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY